PharmaDrug reports interim positive findings for combination of cepharanthine and frontline chemotherapy for IND-enabling prostate cancer study - Proactive Investors Canada

The company reported that a once-per-day oral regimen of PD-001, in combination with cabazitaxel provided statistically significant benefit...

The company reported that a once-per-day oral regimen of PD-001, in combination with cabazitaxel provided statistically significant benefit at the scheduled end of dosing in its ongoing prostate effi… [+2903 chars]

full article...